Bioavailability and intestinal beneficial effect of folate produced by selected lactic acid bacteria in bioenriched fermented milk

A.C.C. CUCICK; A. DE MORENO DE LEBLANC; J.G. LEBLANC; B.D.G.M FRANCO

Sao pablo

Congreso; Ganepao 2019; 2019

Introduction: Folate deficiency is a common public problem that can cause severe health issues. Many countries have adopted mandatory food fortification programs with the synthetic form of the vitamin (folic acid), but excessive intake of folic acid can cause severe undesirable side-effects. Thus, the production of the natural form of this vitamin by selected lactic acid bacteria can be a safe alternative to increase folate intakes. Purpose: The aim of this study was to evaluate the bioavaiability of folate produced by some selected lactic acid bacteria strains in fermented milk, using an animal model.Methods: Five Streptococcus thermophilus (34v, 170v, 361v, 268v e 341 pc) and one Lactobacillus plantarum (16cv) strains, capable of producing folate, were added alone and in co-cultures to skim milk, and tested for folate production after 24h at 37ºC. The co-culture that produced the highest folate levels (St. thermophilus 34v and Lb. plantarum 16cv) was tested for bioavailability of the produced folate, using a depletion-repletion model in BALB/c mice (Laiño et al, 2015). The experimental study comprised of 14 days of depletion and 21 days of repletion of vitamin B9. 30 BALB/c mice were randomly divided into 6 groups: 1. control (only control diet); 2. depleted (only deficient diet); 3. depleted-repleted (control diet); 4. bioenriched fermented milk (BFM) (milk fermented with the selected strains); 5. unfermented milk (pasteurized milk) and 6. unfermented milk added of folic acid (same concentration of the BFM). The mice were sacrificed at the end of the experiments (35 days) by cardiac puncture, and the blood, kidneys, liver, spleen and intestine were removed for quantification of folate by the microbiological assay method (Horne & Patterson, 1988). The intestine was also submitted to histological tests. Results: The highest amount of folate produced by co-cultures was 300 ng/mL (St. thermophilus 34v and Lb. plantarum 16cv). The concentration of folate in the liver, spleen and red blood cells was higher in the BFM group compared to the depleted group, and was similar to that in the depleted-repleted and control groups. The hemogram indicated that haemoglobin, haematocrit and red blood cells were higher in the BFM group than in the control group, while these indicators were lower in the depleted group. Folic acid added to the milk did not affect these indicators. At the intestinal level, the depleted group caused a decrease of the villi length and an increase in the crypts length, meaning that the absence of this vitamin damages the intestinal mucosa. The BFM and the milk with folic acid resulted in a good villi/crypt length relation, equal or better than the control group. Conclusion: To the best of our knowledge, this was the first intestinal level study in mice that found beneficial health outcomes of the intake of a bioenriched fermented milk with selected folate producing LAB. In addition,  the increase of the haemoglobin, haematocrit and red blood cells suggest that the bioenriched fermented milk had a beneficial effect in the animal. This reiterates that vitamin B9 produced by lactic acid bacteria is a good alternative to raise the intake of folate by the population.